SPONSOR
Jemincare
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: ADPKD (Autosomal Dominant Polycystic Kidney Disease)Chronic Spontaneous Urticaria
Jemincare is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including ADPKD (Autosomal Dominant Polycystic Kidney Disease), Chronic Spontaneous Urticaria.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jemincare
How many clinical trials has Jemincare sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Jemincare, of which 2 are actively recruiting participants. These trials cover conditions including ADPKD (Autosomal Dominant Polycystic Kidney Disease), Chronic Spontaneous Urticaria. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jemincare research focus on?
Jemincare clinical trials span ADPKD (Autosomal Dominant Polycystic Kidney Disease), Chronic Spontaneous Urticaria. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jemincare clinical trial?
To participate in a Jemincare trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jemincare trials with current recruitment status updated daily.
Clinical Trials by Jemincare
NCT06800651 Phase 2
Recruiting
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT06509334 Phase 2
Recruiting
Trial of JYB1904 in Chronic Spontaneous Urticaria.
Chronic Spontaneous Urticaria
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology